NASDAQ:GTXI GTX (GTXI) Stock Price, News & Analysis → Rich Dad Poor Dad Author Shocks Millions With 2024 Crash Warning (From American Hartford Gold Group) (Ad) Free GTXI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$8.52▼$8.8050-Day Range$1.20▼$7.2052-Week Range$0.74▼$25.60Volume1,600 shsAverage Volume390,540 shsMarket Capitalization$205.51 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Get GTX alerts: Email Address Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. About GTX Stock (NASDAQ:GTXI)GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for the treatment of stress urinary incontinence (SUI) and prostate cancer. It develops selective androgen receptor modulators (SARMs) for the treatment of breast cancer, SUI, and Duchenne muscular dystrophy; and selective androgen receptor degraders to treat progressive castration-resistant prostate cancer. The company's SARM product candidate is the enobosarm GTx-024, a Phase II proof-of-concept clinical trial for patients with androgen receptor (AR) positive triple-negative breast cancer; and estrogen receptor positive and AR positive advanced breast cancer, as well as postmenopausal women with SUI. GTx, Inc. was founded in 1997 and is headquartered in Memphis, Tennessee.Read More Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. GTXI Stock News HeadlinesApril 25, 2024 | investorplace.comGTX Stock Earnings: Garrett Motion Beats EPS, Misses Revenue for Q1 2024April 22, 2024 | msn.comThe Witcher 3: Wild Hunt Mods Now Available on SteamApril 25, 2024 | American Hartford Gold Group (Ad)Rich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.April 22, 2024 | msn.com5 Of The Best Affordable Graphics Cards You Can Get In 2024April 22, 2024 | msn.comOriginal Joe Dirt Dodge Charger Daytona Movie Car Sells for $330,000April 18, 2024 | markets.businessinsider.comBuy Rating on Ultragenyx Pharmaceutical Bolstered by GTX-102’s Promise and Positive Valuation OutlookApril 17, 2024 | msn.comExclusive: Former ministry official leads GTX-A rail project with hefty compensationApril 17, 2024 | msn.comSony’s new PlayStation PC overlay and shared Trophies arrive with Ghost of TsushimaApril 25, 2024 | American Hartford Gold Group (Ad)Rich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.April 17, 2024 | bizjournals.comUS Farathane, a supplier to Tesla and other automakers, sees Austin metro as a key part of its growthApril 14, 2024 | msn.comRestoring a Classic: 1970 Plymouth Road Runner Barn FindApril 10, 2024 | markets.businessinsider.comBuy Rating for Garrett Motion Backed by Strategic Shift Towards Zero Emission and Hybrid Market GrowthApril 4, 2024 | msn.comHow Do You Like Your Mopar B-body Muscle: Coronet R/T Convertible or GTX Hardtop Coupe?March 25, 2024 | msn.comPlymouth GTX: A Classic Muscle Car’s Rise in Collector’s ValueMarch 21, 2024 | msn.comVolkswagen reveals hot new ID Buzz GTXMarch 21, 2024 | msn.comThe Volkswagen ID. Buzz GTX Is a Spicy Electric Van With 335 HPMarch 21, 2024 | msn.comVolkswagen ID. Buzz GTX Is A Hot Electric Minivan With 335 HP And All-Wheel DriveMarch 19, 2024 | msn.comVolkswagen Unveils ID.3 and Tourer GTX in Electrifying New VideoMarch 18, 2024 | msn.comVolkswagen Unveils New ID.3 and Tourer GTX EVs in Official VideoMarch 15, 2024 | msn.comThe design and equipment of the Volkswagen ID.3 GTXMarch 14, 2024 | msn.comVW ID.7 GTX Tourer: High-Performance Electric Wagon PreviewMarch 14, 2024 | msn.comNew GTX Performance Models Elevate Volkswagen’s ID.3 and ID.7 Tourer Electric VehiclesMarch 14, 2024 | msn.comVW Reveals ID.3 GTX And ID.7 GTX Tourer: High-Performance EVs For EuropeMarch 14, 2024 | msn.comVolkswagen Introduces ID.7 GTX Tourer, Boasting Greater Power Than Golf RMarch 14, 2024 | msn.comVolkswagen ID.3 GTX debuts as brand’s first electric hot hatchMarch 13, 2024 | msn.comIs the VW ID.3 GTX the electric hot hatch you’ve been waiting for?March 13, 2024 | msn.comThe 322-HP ID.3 GTX Is Volkswagen's First Electric Hot HatchSee More Headlines Receive GTXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2018Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryBiotechnology Current SymbolNASDAQ:GTXI CUSIP40052B10 CIK1260990 Webwww.gtxinc.com Phone901-523-9700FaxN/AEmployees21Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-38,420,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-104.19% Return on Assets-86.42% Debt Debt-to-Equity RatioN/A Current Ratio12.39 Quick Ratio12.39 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.09 per share Price / Book7.84Miscellaneous Outstanding Shares24,050,000Free FloatN/AMarket Cap$205.51 million OptionableNot Optionable Beta2.22 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Robert James Wills B.S. (Age 65)M.S., Ph.D., Exec. Chairman Mr. Marc S. Hanover (Age 56)Co-Founder, CEO & Director Mr. Henry P. Doggrell (Age 70)VP, Chief Legal Officer & Sec. Mr. Jason T. Shackelford (Age 44)VP of Fin. & Accounting, Principal Financial & Accounting Officer and Corp. Controller Dr. Diane C. Young (Age 62)VP & Chief Medical Officer Key CompetitorsMerrimack PharmaceuticalsNASDAQ:MACKRigel PharmaceuticalsNASDAQ:RIGLVerastemNASDAQ:VSTMRegulus TherapeuticsNASDAQ:RGLSVanda PharmaceuticalsNASDAQ:VNDAView All Competitors GTXI Stock Analysis - Frequently Asked Questions How were GTX's earnings last quarter? GTx, Inc. (NASDAQ:GTXI) announced its quarterly earnings results on Thursday, November, 15th. The biopharmaceutical company reported ($0.39) earnings per share for the quarter, missing analysts' consensus estimates of ($0.30) by $0.09. What other stocks do shareholders of GTX own? Based on aggregate information from My MarketBeat watchlists, some companies that other GTX investors own include Corbus Pharmaceuticals (CRBP), Synergy Pharmaceuticals (SGYP), Novavax (NVAX), Inovio Pharmaceuticals (INO), Verastem (VSTM), Catalyst Pharmaceuticals (CPRX), MEI Pharma (MEIP), Progenics Pharmaceuticals (PGNX), Rigel Pharmaceuticals (RIGL) and Amarin (AMRN). This page (NASDAQ:GTXI) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GTx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.